Propranolol in Patients with Angina Pectoris
Authors: RALPH E. GIANELLY
Journal: Annals of Internal Medicine (1967)

Article1 December 1967Propranolol in Patients with Angina PectorisRALPH E. GIANELLY, M.D., ROBERT H. GOLDMAN, M.D., BERNARD TREISTER, M.D., DONALD C. HARRISON, M.D.RALPH E. GIANELLY, M.D., ROBERT H. GOLDMAN, M.D., BERNARD TREISTER, M.D., DONALD C. HARRISON, M.D.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-67-6-1216 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptSeveral studies have indicated that propranolol (1-(isopropylamino)-3-(1-naphthyloxy)-2-propranol) hydrochloride, a beta-adrenergic blocking drug, may be useful in the treatment of angina pectoris. The drug has been reported to reduce the frequency and severity of chest pain and to increase exercise tolerance (1-3). Although it appears that propranolol may be helpful in the management of some patients with angina pectoris, it has been impossible to predict which patients will be helped. A simple test to separate a priori those patients who would respond to propranolol from those who would not would be very valuable to clinicians since the drug may have major...References1. HAMERGRANDJEANMELENDEZSOWTON JTLGE: Effect of propranolol (Inderal) in angina pectoris: preliminary report. Brit. Med. J. 2: 720, 1964. CrossrefMedlineGoogle Scholar2. GILLAMPRICHARD PMBN: Use of propranolol in angina pectoris. Brit. Med. J. 2: 337, 1965. CrossrefMedlineGoogle Scholar3. GINNORGAIN WMES: Propranolol hydrochloride in the treatment of angina pectoris, JAMA 198: 1214, 1966. CrossrefMedlineGoogle Scholar4. KRASNOWROLETTYURCHAKHOODGORLIN NELPMWBR: Isoproterenol and cardiovascular performance. Amer. J. Med. 37: 514, 1964. CrossrefMedlineGoogle Scholar5. EPSTEINROBINSONKAHLERBRAUNWALD SBRLE: Effects of beta-adrenergic blockade on the cardiac response to maximal and submaximal exercise in man. J. Clin. Invest. 44: 1745, 1965. CrossrefMedlineGoogle Scholar6. SONNENBLICKROSSCOVELLKAISERBRAUNWALD EHJJWGAE: Velocity of contraction as a determinant of myocardial oxygen consumption. Amer. J. Physiol. 209: 919, 1965. CrossrefMedlineGoogle Scholar7. WOLFSONHEINLEHERMANKEMPSULLIVANGORLIN SRMHJR: Propranolol and angina pectoris. Amer. J. Cardiol. 18: 345, 1966. CrossrefMedlineGoogle Scholar8. MORALES-AGUILERÁVAUCHAN WILLIAMS AEM: The effects on cardiac muscle of beta-receptor antagonists in relation to their activity as local anaesthetics. Brit. J. Pharmacol. 24: 332, 1965. Google Scholar9. LESZKOVOZKYTARDOS GL: Some effects of propranolol on the central nervous system. J. Pharm. Pharmacol. 17: 518, 1965. CrossrefMedlineGoogle Scholar10. MCKENNACOLLINSSIALERZARNSTORFFCRUMPTONROWE DHRJSWCG: Effect of propranolol on systemic and coronary hemodynamics at rest and during simulated exercise. Circ. Res. 19: 520, 1966. CrossrefMedlineGoogle Scholar11. BIRKETTCHAMBERLAIN DADA: Beta-adrenergic blockade in angina pectoris: a method of treadmill assessment. Brit. Med. J. 2: 500, 1966. CrossrefMedlineGoogle Scholar12. ERICKSONSIMONSONTAYLORALEXANDERKEYS LEHLHA: The energy cost of horizontal and grade walking on the motor-driven treadmill. Amer. J. Physiol. 145: 391, 1945. CrossrefGoogle Scholar13. BALKEWARE BR: An experimental study of "physical fitness" of Air Force personnel. U. S. Armed Forces Med. J. 10: 680, 1959. Google Scholar14. VON EULER US: Noradrenaline: Chemistry, Physiology, Pharmacology and Clinical Aspects. Charles C Thomas, Publisher, Springfield, Ill., 1956. CrossrefGoogle Scholar15. CROUT RJ: Standard Methods of Clinical Chemistry, vol. III. Academic Press, Inc., Publishers, New York, 1961, pp. 62-80. Google Scholar16. COLEKAYEGRIFFITH SLHGC: Assay of antianginal agents—the rapport period. JAMA 168: 275, 1958. CrossrefMedlineGoogle Scholar17. ROBINSON BF: The Relation of Heart Rate and Systolic Blood Pressure to the Onset of Pain in Angina Pectoris. Thesis for the degree of M.D., University of London, 1966. Google Scholar18. RABKINSTABLESLEVINSUZMAN RDNM: The prophylactic value of propranolol in angina pectoris. Amer. J. Cardiol. 18: 370, 1966. CrossrefMedlineGoogle Scholar19. KEELAN P: Double-blind trial of propranolol (Inderal) in angina pectoris. Brit. Med. J. 1: 897, 1965. CrossrefMedlineGoogle Scholar20. CHAMBERLAIN C: Effects of beta-adrenergic blockade on heart size. Amer. J. Cardiol. 18: 321, 1966. CrossrefMedlineGoogle Scholar21. APTHORPCHAMBERLAINHAYWARD GHDAGW: The effects of sympathectomy on the electrocardiogram and effort tolerance in angina pectoris. Brit. Heart J. 26: 218, 1964. CrossrefMedlineGoogle Scholar22. SONNENBLICKBRAUNWALDWILLIAMSGLICK EHEJFG: Effects of exercise on myocardial force-velocity relations in intact unanesthetized man: relative roles of changes of heart rate, sympathetic activity, and ventricular dimensions. J. Clin. Invest. 44: 2051, 1965. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAuthors: RALPH E. GIANELLY, M.D.; ROBERT H. GOLDMAN, M.D.; BERNARD TREISTER, M.D.; DONALD C. HARRISON, M.D.Affiliations: Palo Alto, CaliforniaFrom the Cardiology Division, Department of Medicine, Stanford University School of Medicine, Palo Alto, Calif.This study was supported by grants HE-09058-03 and ITL HE-05709-01, National Heart Institute, National Institutes of Health, Bethesda, Md., and grant FR-70, General Clinical Research Grants Branch, U. S. Public Health Service, Washington, D. C.At the time of this study Dr. Gianelly was a Research Fellow in the Cardiology Division, Department of Medicine, Stanford University School of Medicine.Requests for reprints should be addressed to Donald C. Harrison, M.D., Chief, Cardiology Division, Stanford University Medical Center, Palo Alto, Calif. 94305. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byDonald Carey Harrison, MD: A Conversation With the Editor⁎⁎This series of interviews was underwritten by an unrestricted grant from Bristol-Myers Squibb.Efficacy of nifedipine and isosorbide mononitrate in combination with atenolol in stable anginaEffects of nifedipine on myocardial perfusion during exercise in chronic stable angina pectorisThe influence of beta-adrenoceptor blockers with and without intrinsic sympathomimetic activity on heart rate, arrhythmias and ST-T segments, using ambulatory electrocardiography.Class II antiarrhythmic agentsβ-Adrenergic BlockersA single-blind, placebo-controlled study of effects of atenolol on transient ischemia in "mixed" anginaEffect of propranolol on indices of intermittent myocardial ischemia, assessed by exercise testing and ambulatory st-segment monitoringTherapeutic choices in unstable anginaEffect of the addition of propranolol to therapy with nifedipine for unstable angina pectoris: a randomized, double-blind, placebo-controlled trial.The effect and usefulness of early intravenous beta blockade in acute myocardial infarctionAddition of nifedipine to maximal beta-blocker-nitrate therapy: Effects on exercise capacity and global left ventricular performance at rest and during exerciseEffect of beta-adrenergic blockade on the results of exercise testing related to the extent of coronary artery diseaseβ-Adrenoceptor Blocking Agents"Maximal" drug therapy is not necessarily optimal in chronic angina pectorisEffect of metoprolol on chest pain in acute myocardial infarction.Beta-adrenoceptor blocking drugs: Adverse reactions and drug interactionsTHERAPEUTIC PROGRESS-REVIEW V: TREATMENT OF ANGINAInvestigational Drug InformationThe effect of pindolol on myocardial blood flow, metabolism and function during rest and pacing in patients with coronary heart disease.Comparison of antianginal efficacy of one conventional and three long acting beta-adrenoreceptor blocking agents in stable angina pectoris.The combination of nifedipine and propranolol in the management of patients with angina pectoris.Clinical Features of Adrenergic Agonists and Antagonistsβ-Adrenergic Antagonists in Angina and Myocardial InfarctionEffects of acebutolol on chronic stable angina pectoris. A placebo-controlled, double-blind, randomized crossover study.Propranolol Dosing Prior to Coronary Artery Bypass SurgeryManagement of Stable Effort Angina PectorisPraecordial surface mapping after exercise in evaluation of propranolol for angina pectoris.Comparison of five beta-adrenoreceptor antagonists with different ancillary properties during sustained twice daily therapy in angina pectorisComprehensive analysis of exertional ECG changes before and after oral propranololPropranolol in angina pectoris: Duration of improved exercise tolerance and circulatory effects after acute oral administrationAcute effects of oral propranolol on hemodynamic responses to upright exerciseClinical pharmacology of the new beta-adrenergic blocking drugs. Part 2. Physiologic and metabolic effectsMechanism of propranolol withdrawal phenomena.Comparison of the Immediate Effects of Five β-Adrenoreceptor-Blocking Drugs with Different Ancillary Properties in Angina PectorisBeneficial effect of continuation of propranolol through coronary bypass surgeryPropranolol in the treatment of angina pectoris. Comparison of duration of action in acute and sustained oral therapy.Antianginal drugsBeta-adrenoceptor blockade and anaesthesia.Effects of Passive SmokingSafety and Rationale for Continuation of Propranolol Therapy During Coronary Bypass Operationβ-Blockers Continued from page 21Pharmacodynamics of Inotropic and Chronotropic Responses to Oral Therapy with PropranololEinfluß von Pindolol auf Myokarddurchblutung, -Stoffwechsel und Funktion in Ruhe und unter Frequenzstimulation bei Patienten mit koronarer HerzerkrankungPropranolol for patients with mitral valve prolapseEffects of propranolol on coronary hemodynamic and metabolic responses to tachycardia stress in patients with and without coronary diseaseSudden Withdrawal of Propranolol in Patients with Angina PectorisPropranolol therapy in patients undergoing myocardial revascularizationA Double-Blind Trial of Penbutolol: A New Beta-Receptor Blocking Agent in the Treatment of Angina PectorisIneffectiveness of practolol induced beta-blockade in the treatment of angina pectorisPainless ST-Segment Depression in Patients with Angina PectorisLong-term propranolol therapy for angina pectorisEffects of Metoprolol in Angina PectorisDiscontinuation of Propranolol TherapyCorrelation of plasma propranolol concentration with therapeutic response in patients with angina pectoris.Left ventricular wall motion response to intravenous propranolol.Dose response effectiveness of propranolol for the treatment of angina pectoris.Noninvasive assessment of clinical response to oral propranolol therapyMedical Perspectives in Coronary Artery Surgery—A CaveatW. BRUCE DUNKMAN, M.D., JOSEPH K. PERLOFF, M.D., F.A.C.P., JOHN A. KASTOR, M.D., F.A.C.P., JAMES C. SHELBURNE, M.D., F.A.C.P.PropranololMyocardial infarction after propranolol withdrawalEFFECTS OF TIPRENOLOL, PRACTOLOL AND PROPRANOLOL ON EXPERIMENTAL VENTRICULAR TACHYARRHYTHMIASTreatment of Angina PectorisTreatment of Angina PectorisPropranololHOWARD F. MORRELLI, M.D., F.A.C.P.HAEMODYNAMIC EFFECTS OF β-RECEPTOR BLOCKING AGENTS AND DIGITALIS IN ISCHAEMIC CORONARY HEART DISEASE WITH ANGINA PECTORISThe medical treatment of angina pectoris VI. Propranolol as an antianginal drugThe effect of β-adrenergic blockade on cardiac responses to orthostatic stressCirculatory responses to beta adrenergic blockade with alprenololMedical management of patients with angina pectorisAngina Pectoris: Pathophysiology, Evaluation, and TreatmentSTEPHEN E. EPSTEIN, M.D., DAVID R. REDWOOD, M.D., ROBERT E. GOLDSTEIN, M.D., G. DAVID BEISER, M.D., DOUGLAS R. ROSING, M.D., D. LUKE GLANCY, M.D., ROBERT L. REIS, M.D., EDWARD B. STINSON, M.D.Exercise tolerance in patients with angina pectorisDiagnostic and Therapeutic Aspects of Stable Angina PectorisCoronary flow changes and cardiac adrenergic blockade during nitroglycerin infusionsHuman Cardiovascular Effects of Alprenolol, A Beta‐Adrenergic Blocker: Hemodynamic, Antiarrhythmic, and Antianginalβ-ReceptorenblockerTherapy of Angina Pectoris with Propranolol and Long-Acting NitratesThe effect of propranolol on exercise-induced ischemic S-T segment depressionBeta-adrenergic blocking agents for the treatment of angina pectorisBeta-blockade and angina pectoris: a controlled multi-centre clinical trialPropranolol Combined with Isosorbide Dinitrate versus Placebo in Angina PectorisNew Drugs in the Treatment of AnginaPROPRANOLOL IN ANGINA PECTORISEffects of Propranolol and Isosorbide Dinitrate on Exercise Performance and Adrenergic Activity in Patients with Angina PectorisChronic beta adrenergic receptor blockade in the treatment of idiopathic hypertrophic subaortic stenosisInhibition of the Adrenergic Nervous System in the Treatment of Angina PectorisChapter 8 Angina Pectoris and Antianginal Agents 1 December 1967Volume 67, Issue 6Page: 1216-1225KeywordsAnginaDrugsExerciseHeartIschemiaLongitudinal studiesMedical servicesResearch grants ePublished: 1 December 2008 Issue Published: 1 December 1967 PDF downloadLoading ...